O Brien Wealth Partners LLC Has $3.32 Million Stake in LifeStance Health Group, Inc. (NASDAQ:LFST)

O Brien Wealth Partners LLC lessened its stake in LifeStance Health Group, Inc. (NASDAQ:LFST) by 24.9% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 537,901 shares of the company’s stock after selling 178,281 shares during the quarter. LifeStance Health Group accounts for about 0.8% of O Brien Wealth Partners LLC’s holdings, making the stock its 17th biggest position. O Brien Wealth Partners LLC’s holdings in LifeStance Health Group were worth $3,319,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Assetmark Inc. lifted its stake in shares of LifeStance Health Group by 21.6% in the 4th quarter. Assetmark Inc. now owns 11,895 shares of the company’s stock valued at $93,000 after purchasing an additional 2,114 shares during the last quarter. Sunbelt Securities Inc. bought a new stake in shares of LifeStance Health Group during the 3rd quarter worth $34,000. Charles Schwab Investment Management Inc. raised its holdings in LifeStance Health Group by 0.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 744,617 shares of the company’s stock worth $5,830,000 after acquiring an additional 5,112 shares during the period. SG Americas Securities LLC raised its holdings in LifeStance Health Group by 37.6% in the 4th quarter. SG Americas Securities LLC now owns 41,325 shares of the company’s stock worth $324,000 after acquiring an additional 11,295 shares during the period. Finally, Stratos Wealth Partners LTD. bought a new position in LifeStance Health Group in the 4th quarter worth $93,000. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Danish J. Qureshi sold 150,000 shares of the business’s stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $5.21, for a total value of $781,500.00. Following the transaction, the insider now directly owns 439,002 shares in the company, valued at $2,287,200.42. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other LifeStance Health Group news, insider Danish J. Qureshi sold 150,000 shares of the business’s stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $5.21, for a total value of $781,500.00. Following the transaction, the insider now directly owns 439,002 shares in the company, valued at $2,287,200.42. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the business’s stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $5.89, for a total transaction of $22,395,812.05. Following the completion of the transaction, the insider now owns 41,932,358 shares in the company, valued at $246,981,588.62. The disclosure for this sale can be found here. Insiders have sold a total of 4,087,716 shares of company stock valued at $24,010,444 over the last quarter. 6.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts recently commented on LFST shares. Morgan Stanley reiterated an “overweight” rating and issued a $10.00 target price on shares of LifeStance Health Group in a report on Monday, April 22nd. Jefferies Financial Group boosted their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a report on Wednesday, March 6th. Finally, The Goldman Sachs Group boosted their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Monday, March 4th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $8.80.

LifeStance Health Group Stock Up 1.0 %

NASDAQ LFST traded up $0.05 on Monday, reaching $4.96. The company’s stock had a trading volume of 1,119,686 shares, compared to its average volume of 1,469,465. The business has a 50-day moving average price of $6.02 and a 200 day moving average price of $6.48. LifeStance Health Group, Inc. has a 52 week low of $4.64 and a 52 week high of $9.52. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.18 and a current ratio of 1.18.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, May 9th. The company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.03. The business had revenue of $300.44 million for the quarter, compared to analysts’ expectations of $299.02 million. LifeStance Health Group had a negative net margin of 15.69% and a negative return on equity of 11.92%. The firm’s revenue for the quarter was up 18.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.09) earnings per share. Sell-side analysts expect that LifeStance Health Group, Inc. will post -0.26 EPS for the current year.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.